An exploration section allowing simulation of a typical individual and an interactive exploration of parameters and treatments A simulation section allowing simulations of populations and clinical ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it ...
PARIS--(BUSINESS WIRE)--Lixoft, a Simulations Plus company (Nasdaq: SLP), a leading provider of population PKPD modeling solutions for pharmacometricians and biostatisticians, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results